⏳ Fetching live dividend data...
Home › Calculator › CDMO Dividend Calculator 2026
Avid Bioservices, Inc. · NASDAQ
Price: $12.49 · Annual div: $2.00/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Click to apply scenario to the calculator
Year your monthly dividend income covers each expense (based on current settings)
$10,000 in CDMO → $10.79M in 10 years · $0.14/month
Avid Bioservices, Inc. operates as a Contract Development and Manufacturing Organization (CDMO), specializing in the development and CGMP-compliant production of biopharmaceutical drug substances. Their core expertise lies in compounds derived from mammalian cell culture, providing both clinical and commercial scale manufacturing solutions. The company is proficient in producing critical therapeutics such as monoclonal antibodies and recombinant proteins. Beyond manufacturing, their comprehensive service portfolio encompasses CGMP manufacturing for drug substances, bulk packaging, rigorous release and stability testing, and essential regulatory submission and support. Additionally, Avid Bioservices offers a range of process development services, including the optimization of upstream and downstream processes, alongside the development, testing, and characterization of analytical methods. Avid Bioservices primarily serves clients within the biotechnology and biopharmaceutical industries. The company, which was originally incorporated in 1981, was known as Peregrine Pharmaceuticals, Inc. before officially rebranding to Avid Bioservices, Inc. in January 2018. Its corporate headquarters are situated in Tustin, California.
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open CDMO position with:
Real after-tax yield depends on where you live and how you hold CDMO.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 16.01% | 13.21% | $1,601 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 13.61% | 10.81% | $1,361 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 12.81% | 10.01% | $1,281 / yr |
| 🇬🇧 UK ISA | 0% | 16.01% | 13.21% | $1,601 / yr |
| 🇬🇧 UK Taxable | 8.75% | 14.61% | 11.81% | $1,461 / yr |
| 🇨🇦 TFSA | 0% | 16.01% | 13.21% | $1,601 / yr |
| 🇨🇦 CA Taxable | 25% | 12.01% | 9.21% | $1,201 / yr |
| 🇦🇺 Super (pension) | 15% | 13.61% | 10.81% | $1,361 / yr |
| 🇦🇺 AU Taxable | 30% | 11.21% | 8.41% | $1,121 / yr |
| 🇩🇪 DE Taxable | 26.375% | 11.79% | 8.99% | $1,179 / yr |
| 🇫🇷 FR Taxable | 30% | 11.21% | 8.41% | $1,121 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
CDMO pays quarterly — 4 times per year. Next ex-div: TBD.
How CDMO compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for CDMO sourced from FMP /financial-growth endpoint — real data, not estimates.
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
| Insider | Title | Type | Date | Shares | Price | Total Value |
|---|---|---|---|---|---|---|
| D-Return | 2025-02-05 | 14,286 | $9.17 | $131.0K | ||
| D-Return | 2025-02-05 | 21,429 | $3.50 | $75.0K | ||
| D-Return | 2025-02-05 | 1,733 | — | — | ||
| D-Return | 2025-02-05 | 98,120 | $6.07 | $595.6K | ||
| D-Return | 2025-02-05 | 17,679 | — | — | ||
| D-Return | 2025-02-05 | 51,413 | — | — | ||
| D-Return | 2025-02-05 | 55,310 | $6.95 | $384.4K | ||
| D-Return | 2025-02-05 | 108,579 | — | — | ||
| D-Return | 2025-02-05 | 66,799 | — | — | ||
| D-Return | 2025-02-05 | 45,611 | — | — |
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
Analyst consensus price target via FMP. Not a guarantee of future performance. Past analyst accuracy varies.
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the CDMO dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
Avid Bioservices, Inc. (CDMO) is currently trading at $12.49, 61% below its 52-week high. The current dividend yield is 16.01% based on an annual payout of $2.00 per share.
Avid Bioservices, Inc. (CDMO) is a healthcare stock currently trading at $12.49 with a dividend yield of 16.01%. The company pays an annual dividend of $2.00 per share. The payout ratio of 50% suggests the dividend is well-covered by earnings. Over the past 5 years, CDMO has grown its dividend at a compound annual rate of 50.0%.
Auto-generated from live market data. For educational purposes only — not financial advice.
Real users. No sign-up required to leave a review.
“Finally a free dividend calculator that doesn't make me sign up or connect my brokerage. Entered SCHD and got the full DRIP projection in seconds. Bookmarked immediately.”
“I've been trying to figure out how much dividend income I'd need to retire. This tool showed me exactly — $400K in JEPI at 7% yield gives me $2,333/month. No calculator did that this clearly before.”
“Really solid passive income calculator. Covers everything: DRIP compounding, Roth IRA tax savings, DCA contributions. The year-by-year breakdown is what I was missing from other tools.”
“As someone planning retirement in 5 years, this dividend yield calculator showed me I need about 12% more in dividend stocks to hit my income target. Incredibly useful and completely free.”
“The Congress trades tracker is genius. Saw that several senators were buying O (Realty Income) and immediately ran it through the DRIP calculator. Bought 50 shares the next day.”
Reviews reflect users' personal experiences. Not financial advice.
Leave a review →